January 30, 2026 – In an effort to strengthen resilience throughout the U.S. healthcare provide chain and assist home manufacturing, the Facilities for Medicare & Medicaid Providers (CMS) introduced that the company is exploring methods to incentivize hospitals to buy provides and medicines manufactured within the U.S. Underneath the proposal, CMS would set up a “Safe American Medical Provides” designation for hospitals that meet minimal buying thresholds for U.S.-manufactured medical provides, in response to an advance discover of proposed rulemaking (ANPRM). CMS is looking for public enter on the proposal’s reimbursement quantity.

The proposal is much like a cost strategy that CMS launched in 2023 that gives monetary incentives to outpatient clinics and ambulatory surgical procedure facilities that keep a dependable home provide of N95 surgical respirators.

CMS additionally indicated it might introduce a brand new structural high quality measure throughout the Hospital Inpatient High quality Reporting Program, which might require hospitals to display that they’ve met minimal buying thresholds for U.S.-made private protecting gear (PPE) and important medicines.

Learn extra from CMS.